November 29, 2019 Bayer completes sale of Currenta stake to Macquarie Infrastructure and Real AssetsRead more
SPECIALIZED PRESS November 25, 2019 Not intended for U.S. and UK MediaBayer submits application to EMA for use of rivaroxaban in children with venous thromboembolismRead more
November 19, 2019 Not intended for U.S. and UK Media - Neglected Tropical DiseasesBayer expands collaboration with the World Health Organization to fight pork tapeworm infections as cause for epilepsyRead more
SPECIALIZED PRESS November 18, 2019 Not intended for U.S. and UK MediaPhase III VICTORIA study with vericiguat in patients with worsening chronic heart failure meets primary endpointRead more
November 14, 2019 Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseasesRead more
November 10, 2019 Climate FieldView™ Partnership with CLAAS Brings Bayer Data Science to More Farms:Global agreement supports FieldView expansion in Europe and other regionsRead more
November 7, 2019 NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPANBayer refinances 1.75 billion euro hybrid bondRead more
